Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Labcorp Genetics (formerly Invitae) LabCorp United States | 177 | 130 |
|
Invitae Primary Immunodeficiency Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 552 | 424 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 327 | 300 |
|
Invitae Bone Marrow Failure Syndromes Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 137 | 85 |
|
Hyper IgM Syndrome (HIGM): (CD40LG [TNFSF5] for HIGM1 (Known mutation) Molecular Diagnostic Laboratory LabCorp United States | 1 | 1 |
|
Hyper IgM Syndrome (HIGM): (CD40LG [TNFSF5 for HIGM1) (Full Gene Sequencing) Molecular Diagnostic Laboratory LabCorp United States | 1 | 1 |
|
X-Linked Hyper IgM Syndrome via the CD40LG Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Integrated Genetics Westborough LabCorp United States | 330 | 746 |
|
Targeted Variant, Fetal Analysis Integrated Genetics Westborough LabCorp United States | 292 | 746 |
|
Integrated Genetics Westborough LabCorp United States | 287 | 578 |
|
Integrated Genetics Westborough LabCorp United States | 292 | 597 |
|
Integrated Genetics Westborough LabCorp United States | 330 | 746 |
|
Integrated Genetics Westborough LabCorp United States | 287 | 578 |
|
Severe Combined Immunodeficiency Asper Biogene Asper Biogene LLC Estonia | 61 | 43 |
|
Al Jalila Children’s Genomics Center Al Jalila Childrens Speciality Hospital United Arab Emirates | 25 | 25 |
|
Primary Antibody Deficiency NGS Panel Fulgent Genetics United States | 102 | 37 |
|
Comprehensive Primary Immunodeficiency NGS Panel Fulgent Genetics United States | 1048 | 472 |
|
Severe Combined Immunodeficiency NGS Panel Fulgent Genetics United States | 330 | 90 |
|
Beacon Expanded Female Carrier Screening Plus Panel Fulgent Genetics United States | 716 | 335 |
|
Beacon Expanded Female Carrier Screening Panel Fulgent Genetics United States | 690 | 326 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.